/newsroom/taxonomy/term/986/all en /newsroom/channels/news/expert-science-behind-seasonal-mood-changes-361279 <p>Seasonal Affective Disorder (SAD) is a type of depression linked to the changing seasons, particularly during fall and winter when daylight hours decrease. The reduced sunlight and lower vitamin D levels can lead to changes in mood, energy and sleep patterns. As well, the recent change back to standard time from daylight savings can disrupt circadian rhythms, with similar results.  </p> Mon, 18 Nov 2024 21:32:18 +0000 keila.depape@mcgill.ca 314833 at /newsroom /newsroom/channels/news/parenting-programs-help-kids-provide-insufficient-support-parents-study-finds-360264 <p><!-- x-tinymce/html --></p> <p>Parenting programs that address both mental health and parenting skills can improve children’s development, but often fall short when it comes to offering effective mental-health support for parents, new research suggests.</p> <p>“It’s a surprising contradiction,” said the study’s lead author,<a href="/newsroom/marilyn-ahun"> Marilyn Ahun</a>, Assistant Professor in the Department of Medicine at Ď㽶ĘÓƵ. “Our findings show the potential of multi-component programs, while revealing gaps that need to be addressed.”</p> Tue, 08 Oct 2024 20:54:54 +0000 keila.depape@mcgill.ca 314692 at /newsroom /newsroom/channels/news/covid-19-lockdowns-deepened-struggle-work-family-balance-334723 <p>Around the world increasing mental health inequalities between women and men following the COVID-19 pandemic represent a major public health concern. According to a new study, the lockdown measures due to the pandemic profoundly and unequally disrupted the work-family balance for many graduate students, exacerbating mental health problems.</p> Wed, 10 Nov 2021 15:01:57 +0000 shirley.cardenas@mcgill.ca 283615 at /newsroom /newsroom/channels/news/new-use-old-drug-how-does-ketamine-combat-depression-327092 <p>A group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain, according to researchers from three Canadian universities. The <a href="https://www.nature.com/articles/s41586-020-03047-0">discovery</a> could lead to better and safer treatments for certain patients suffering from major depression.</p> Tue, 15 Dec 2020 23:38:03 +0000 shirley.cardenas@mcgill.ca 253379 at /newsroom /newsroom/soham-rej Wed, 09 Dec 2020 18:32:43 +0000 frederique.mazerolle@mcgill.ca 252633 at /newsroom /newsroom/channels/news/strong-social-support-decreases-mental-health-problems-young-adults-326716 <p>Early adulthood, a transitional life stage marked by major changes in social roles and responsibilities, can bring with it an increase of mental health problems. A team of Ď㽶ĘÓƵ researchers has found that young adults who perceived higher levels of social support reported fewer mental health problems.</p> Fri, 04 Dec 2020 16:00:23 +0000 frederique.mazerolle@mcgill.ca 252058 at /newsroom /newsroom/channels/news/promising-advance-depression-research-321494 <p>Depression is a common psychiatric disorder and one of the leading causes of disability worldwide. Antidepressants are the first-line treatment for moderate to severe major depressive episodes. Despite their effectiveness, only 40% of patients respond to the first antidepressant they try. A recent paper in <a href="https://www.nature.com/articles/s41467-020-15423-5">Nature Communication</a> strongly suggests that a particular protein, GPR56, is involved in the biology of depression and the effect of antidepressants.</p> Tue, 07 Apr 2020 16:20:23 +0000 amelia.souffrant@mail.mcgill.ca 207065 at /newsroom /newsroom/channels/news/new-molecular-target-identified-depression-287058 <p>The discovery of a new mechanism involved in depression – and a way to target it with a drug as effective as classical antidepressants -- provides new understanding of this illness and could pave the way for treatments with fewer side effects.</p> Mon, 07 May 2018 14:23:36 +0000 justin.dupuis@mcgill.ca 39464 at /newsroom /newsroom/channels/news/flawed-research-methods-exaggerate-prevalence-depression-283951 <p>An over-reliance on self-report screening questionnaires, wherein patients essentially define their own condition, in place of diagnostic interviews conducted by a health care professional, has resulted in over-estimation of the prevalence of people with depression in many research studies – often by a factor of two to three times. This is according to a study published in the Canadian Medical Association Journal. The study found that over 75% of recent research on depression prevalence has been based exclusively on patient completed questionnaires.</p> Thu, 18 Jan 2018 14:28:57 +0000 mona.noonoo@mail.mcgill.ca 32843 at /newsroom /newsroom/channels/news/speeding-ssris-269228 <p>For people suffering from depression, a day without treatment can seem like a lifetime. A new study explains why the most commonly prescribed antidepressants can take as long as six weeks to have an effect. The findings could one day lead to more effective and faster acting drugs.</p> Thu, 03 Aug 2017 19:14:11 +0000 priya.pajel@mail.mcgill.ca 32138 at /newsroom /newsroom/channels/news/depression-screening-children-and-adolescents-261911 <p><a href="/newsroom/"><strong><em>McGill Newsroom</em></strong></a></p> <p><em>Researchers find tools inaccurate and advise against routine screening in this age group</em></p> Tue, 02 Aug 2016 14:23:23 +0000 nima.adibpour@mail.mcgill.ca 26052 at /newsroom /newsroom/channels/news/antidepressants-rise-label-prescriptions-260949 <p><strong><em><a href="/newsroom">McGill Newsroom</a></em></strong></p> <p>Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing antidepressants for nondepressive indications, including unapproved (off-label) indications that have not been evaluated by regulatory agencies.</p> Tue, 24 May 2016 13:45:21 +0000 nima.adibpour@mail.mcgill.ca 25875 at /newsroom /newsroom/channels/news/how-depression-may-compound-risk-type-2-diabetes-260358 <p><strong><em>By Fergus Grieve, <a href="/newsroom">McGill Newsroom</a></em></strong></p> <p><em>Depression, metabolic factors combine to boost risk of developing diabetes, study finds </em></p> <p>Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from Ď㽶ĘÓƵ, l'UniversitĂ© de MontrĂ©al, the Institut de recherches cliniques de MontrĂ©al and the University of Calgary.</p> Tue, 12 Apr 2016 14:27:45 +0000 nima.adibpour@mail.mcgill.ca 25701 at /newsroom /newsroom/channels/news/vulnerability-depression-linked-noradrenaline-258606 <p><em><strong>By Bruno Geoffroy, <a href="https://www.ciusss-ouestmtl.gouv.qc.ca/en/home/">Centre intĂ©grĂ© universitaire de santĂ© et de services sociaux de l’Ouest-de-l’Île-de-MontrĂ©al</a></strong></em></p> <p><em>First-ever connection between noradrenergic neurons and vulnerability to depression</em></p> Mon, 15 Feb 2016 15:56:32 +0000 nima.adibpour@mail.mcgill.ca 25292 at /newsroom /newsroom/gustavo-turecki Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 22656 at /newsroom